July 10, 2025

Investigating kinase activity in living cells

Investigating kinase activity in living cells

Scientists build molecular recording tool

The ability of protein kinases to transfer a phosphate group to target proteins plays an important role in many cellular processes. Scientists at the Max Planck Institute for Medical Research in Heidelberg have now developed a novel molecular tool that can monitor these kinase activities both spatially and temporally. This makes it possible to investigate the link between kinase activities and cellular phenotypes in heterogenous cell populations and in vivo.

In the simultaneous presence of the fluorescent HaloTag substrate (magenta) and a specific kinase activity, the molecular recorder Kinprola (green) becomes labeled and thus tracks specific kinase activities.
© MPI for Medical Research
  • The newly developed recorder named Kinprola is based on a mechanism that is triggered when two split fragments of the self-labeling protein HaloTag are rejoined. Self-labeling proteins have the ability to mark themselves with color.
  • In the presence of both the fluorescent HaloTag substrate as well as a specific kinase activity, Kinprola becomes labeled. The kinase activity controls how intense the labeling is, while the fluorescent substrate determines the recording time.
  • The scientists designed recorders for four protein kinases. The publication of the study in the journal Nature Chemical Biology focusses mainly on protein kinase A (PKA).

Protein kinases, an important subgroup of kinases, control most cellular processes. Their activity is crucial for regular cell processes, whereas aberrant kinase activity is involved in numerous diseases.

Overcoming limitations of optical imaging

“We wanted to find a way to record kinase activities in a scalable and high-resolution manner, without the restrictions of optical imaging. Under the microscope, observations are typically limited to real-time imaging of a relatively small number of cells and are not readily applicable to deep tissues”, says De-en Sun, who led the project team together with Kai Johnsson, director at the Max Planck Institute (MPI) for Medical Research.

Key: converting transient kinase activity into a stable fluorescent signal

Kinprola enables decoupled recording and analysis, works for multiple kinases, and functions in vivo.
© MPI for Medical Research

With their molecular recorder Kinprola, the Max Planck scientists found a way to overcome the limitations of real-time optical recording. They make use of a molecular switch depending on phosphorylation, a process that is catalyzed by kinases. When this kinase is activated, recording is initiated by washing in a fluorescent substrate, which enables labeling of activated Kinprola proteins. The recording is terminated by washing out the substrate. The labeled Kinprola population remains stable over time, while the rest of the Kinprola protein pool remains unlabeled.

This procedure enables decoupled recording and analysis, using different imaging techniques and flow cytometry – a technique that enables the physical and chemical properties of cells or other particles to be analyzed and sorted –, depending on the experiment. It converts transient kinase activity into a stable fluorescent signal, and is characterized by its high versatility and scalability. Kinprola works for multiple kinases, and functions in vivo. In mouse brains, for instance, Kinprola can record PKA activation elevated by drug injection.

Cooperation partners from the Heidelberg scientific community and China

De-en Sun from the MPI for Medical Research in Heidelberg is supported by the Humboldt Research Fellowship and an interinstitutional postdoctoral fellowship of the Health + Life Science Alliance Heidelberg Mannheim. Scientists at the German Cancer Research Center (DKFZ) and Heidelberg University contributed to the transcriptomics (Frank Winkler and Wolfgang Wick groups) and CRISPR screening (Michael Boutros group). Scientists of the Yulong Li group at the Peking University, China, contributed to the mouse experiments.

Our latest News

discover more
European Biotech Act: bioRN brings Industry and Policymakers together

European Biotech Act: bioRN brings Industry and Policymakers together

How can Europe strengthen its global competitiveness in biotechnology? Heidelberg, July 7th: This question was at the heart of a high-level roundtable hosted by the bioRN Life Science Cluster with Member of the European Parliament Hildegard Bentele. Representatives from Ascendis Pharma, BD, PROGEN, Novaliq, BASF Agricultural Solutions, PEPperPRINT, Evotec and Isenbruck Bösl Hörschler joined the […]

AbbVie Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma

AbbVie Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma

NORTH CHICAGO, Ill., July 6, 2026 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that the European Commission (EC) granted marketing authorization for TEPKINLY® (epcoritamab) in combination with lenalidomide and rituximab (TEPKINLY + R2) for the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma (FL). The approval is based on results from the pivotal Phase 3 […]

Optimized Formula: New Bio-Ink Can Depict the Cell Environment Even More Accurately

Optimized Formula: New Bio-Ink Can Depict the Cell Environment Even More Accurately

It should be biofunctional – that is, it should replicate the natural cellular environment as closely as possible – and it should be printable: bioink. Achieving both of these properties at the same time is an enormous challenge that conventional biomaterials often fail to meet. Together with two partner companies, researchers at the NMI have now taken an important […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp